Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-234 PK/PD Study in Healthy Volunteers
NCT07717775Phase 1Not yet recruiting
- Sponsor
- Addpharma, Inc.
- Start
- Aug 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in gastritis (6 arms), sponsored by Addpharma, Inc. Primary endpoint: Percent of Time With Gastric pH ≥4 at Day 7. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
gastritis
Beyond the preview
Go deeper on NCT07717775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717775.